Case report: A novel PTCH1 frameshift mutation leading to nevoid basal cell carcinoma syndrome

A patient presenting with several basal cell carcinomas, pigmented nevi, and developmental defects was diagnosed with nevoid basal cell carcinoma syndrome. Gene panel sequencing and Sanger sequencing were used to identify a novel heterozygous frameshift mutation, c.1312dupA:p.Ser438Lysfs, in exon 9...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in medicine 2024, Vol.11, p.1327505-1327505
Hauptverfasser: Lang, Xiaoqing, Wang, Ting, Guo, Shuping, Dang, Yao, Zhang, Yingjie, Liu, Hongye, He, Hongxia, Li, Li, Yuan, Huajie, He, Ting, Wang, Qiong, Qin, Shiyu, Cheng, Runping, Yan, Xingquan, Cui, Hongzhou
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A patient presenting with several basal cell carcinomas, pigmented nevi, and developmental defects was diagnosed with nevoid basal cell carcinoma syndrome. Gene panel sequencing and Sanger sequencing were used to identify a novel heterozygous frameshift mutation, c.1312dupA:p.Ser438Lysfs, in exon 9 of PTCH1. I-Tasser and PyMol analyses indicated that the mutated protein patched homolog 1 (PTCH1) lacked 12 transmembrane domains and the intracellular and extracellular rings of ECD2 compared with the wild-type protein, resulting in a remarkably different structure from that of the wild-type protein. This case extends our knowledge of the mutation spectrum of NBCCS.
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2024.1327505